个人声音放大产品与基础助听器及高端助听器的临床性能评估
这项前瞻性单机构队列研究纳入56例轻、中、中重度听力损失受试者,比较个人声音放大产品(PSAP)、基础助听器和高端助听器在言语感知、音质、聆听努力和偏好方面的表现。轻中度组三种设备无实质性差异,而中重度组高端助听器在多数测试中表现更优且70%受试者偏好高端助听器。
要点
- 轻中度听力损失者中,PSAP与基础及高端助听器在言语感知、音质、聆听努力和偏好上无实质性差异。
- 中重度听力损失者中,高端助听器在多数测试中表现更优,70%受试者偏好高端助听器。
- 作者认为PSAP或可作为轻中度听力损失者助听器的替代选择,但听力损失更重时应考虑助听器尤其是高端助听器。
核心结论
- 轻中度听力损失者中基础助听器和高端助听器不优于PSAP,提示PSAP或可作为该类人群助听器的替代选择;听力损失更重时,应考虑助听器尤其是高端助听器作为管理选项。
研究设计与样本
- 前瞻性单机构队列研究,共纳入56例受试者,其中轻度听力损失19例、中度20例、中重度17例。
- 所有受试者分别佩戴PSAP、基础助听器和高端助听器完成4项临床听力测试并填写评估问卷。
- 所有设备由临床医生佩戴以防止偏倚和顺序效应,受试者对所用设备设盲,设备顺序随机化。
主要发现
- 受试者平均年龄56岁(四分位距48-59岁),女性29例(52%)。
- 轻度和中度听力损失组中,PSAP、基础助听器和高端助听器在言语感知(Cohen d=0.06-1.05)、音质(Cohen d=0.06-0.71)、聆听努力(Cohen d=0.10-0.92)和用户偏好(PSAP 41%;基础助听器28%;高端助听器31%)方面无实质性差异。
- 中重度听力损失患者中,高端助听器在多数测试中表现更优(Cohen d=0.60-1.59),70%受试者偏好使用高端助听器。
关键数值与推荐
- 测试包括韩语版噪声下听力测试、噪声下言语清晰度测试、双任务范式聆听努力测量、瞳孔测量法及关于音质和偏好的自评问卷。
- 测试在以下4种听力条件下进行:未助听、使用PSAP、使用基础助听器、使用高端助听器。
临床怎么用
- 作者认为,轻中度听力损失患者中PSAP或可作为助听器的替代选择。
- 作者认为,听力损失更重时应考虑助听器尤其是高端助听器作为管理选项。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hearing loss is a highly prevalent condition with multiple negative associated outcomes, yet few persons with hearing loss have hearing aids (HAs). Personal sound amplification products (PSAPs) could be an alternative low-cost solution to HAs, but data are lacking on the performance of PSAPs. OBJECTIVE: To evaluate the clinical efficacy of a PSAP by comparing its performance with that of a basic HA and a premium HA in participants with mild, moderate, and moderately severe hearing impairment. DESIGN, SETTING, AND PARTICIPANTS: A prospective, single-institution cohort study was performed with a total of 56 participants, including 19 with mild hearing loss, 20 with moderate hearing loss, and 17 with moderately severe hearing loss. All participants underwent 4 clinical hearing tests with each of the PSAP, basic HA, and premium HA, and all completed an evaluative questionnaire. INTERVENTIONS: All hearing devices (PSAP, basic HA, and premium HA) were applied by a clinician to prevent bias and order effects; participants were blinded to the device in use, and sequence of devices was randomized. MAIN OUTCOMES AND MEASURES: The study used the Korean version of the hearing in noise test, the speech intelligibility in noise test, listening effort measurement using a dual-task paradigm, pupillometry, and a self-rating questionnaire regarding sound quality and preference. These tests were administered under the following 4 hearing conditions: unaided hearing, use of PSAP, use of basic HA, and use of premium HA. RESULTS: The study included 56 participants with a mean age of 56 years (interquartile range, 48-59 years); 29 (52%) were women. In the mild and moderate hearing loss groups, there was no meaningful difference between PSAP, basic HA, and premium HA for speech perception (Cohen d = 0.06-1.05), sound quality (Cohen d = 0.06-0.71), listening effort (Cohen d = 0.10-0.92), and user preference (PSAP, 41%; basic HA, 28%; premium HA, 31%). However, for the patients with moderately severe hearing loss, the premium HA had better performance across most tests (Cohen d = 0.60-1.59), and 70% of participants preferred to use the premium HA. CONCLUSIONS AND RELEVANCE: The results indicate that basic and premium HAs were not superior to the PSAP in patients with mild to moderate hearing impairment, which suggests that PSAPs might be used as an alternative to HAs in these patient populations. However, if hearing loss is more severe, then HAs, especially premium HAs, should be considered as an option to manage hearing loss.
引用
- Cho YS, Park SY, Seol HY, et al. Clinical Performance Evaluation of a Personal Sound Amplification Product vs a Basic Hearing Aid and a Premium Hearing Aid. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 31095263. doi:10.1001/jamaoto.2019.0667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。